Lincoln National Corp Laboratory Corp Of America Holdings Transaction History

Lincoln National Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$209.01 - $232.56 $85,903 - $95,582	411 Added 30.95%	1,739 $379,000
Q4 2023 Feb 06, 2024	BUY	$197.69 - $227.29 $262,532 - $301,841	1,328 New	1,328 $301,000
Q2 2023 Aug 04, 2023	BUY	$211.93 - $241.33 $1,907 - $2,171	9 Added 0.95%	957 $230,000
Q1 2023 May 01, 2023	BUY	$213.32 - $257.83 $213 - $257	1 Added 0.11%	948 $217,000
Q4 2022 Feb 07, 2023	BUY	$203.72 - $248.97 $192,922 - $235,774	947 New	947 $222,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.